BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34781889)

  • 21. Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.
    Montemurro N; Fanelli GN; Scatena C; Ortenzi V; Pasqualetti F; Mazzanti CM; Morganti R; Paiar F; Naccarato AG; Perrini P
    Clin Neurol Neurosurg; 2021 Aug; 207():106735. PubMed ID: 34119900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article.
    Chaichana KL; Chaichana KK; Olivi A; Weingart JD; Bennett R; Brem H; Quiñones-Hinojosa A
    J Neurosurg; 2011 Mar; 114(3):587-94. PubMed ID: 20887095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme.
    Chambless LB; Kistka HM; Parker SL; Hassam-Malani L; McGirt MJ; Thompson RC
    J Neurooncol; 2015 Jan; 121(2):359-64. PubMed ID: 25344883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy.
    Kreth FW; Thon N; Simon M; Westphal M; Schackert G; Nikkhah G; Hentschel B; Reifenberger G; Pietsch T; Weller M; Tonn JC;
    Ann Oncol; 2013 Dec; 24(12):3117-23. PubMed ID: 24130262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glioblastoma surgery with and without intraoperative MRI at 3.0T.
    Napolitano M; Vaz G; Lawson TM; Docquier MA; van Maanen A; Duprez T; Raftopoulos C
    Neurochirurgie; 2014 Aug; 60(4):143-50. PubMed ID: 24975207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes.
    Mampre D; Ehresman J; Pinilla-Monsalve G; Osorio MAG; Olivi A; Quinones-Hinojosa A; Chaichana KL
    Br J Neurosurg; 2018 Oct; 32(5):528-535. PubMed ID: 30073866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma.
    Rahman M; Abbatematteo J; De Leo EK; Kubilis PS; Vaziri S; Bova F; Sayour E; Mitchell D; Quinones-Hinojosa A
    J Neurosurg; 2017 Jul; 127(1):123-131. PubMed ID: 27689459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. When gross total resection of a glioblastoma is possible, how much resection should be achieved?
    Chaichana KL; Cabrera-Aldana EE; Jusue-Torres I; Wijesekera O; Olivi A; Rahman M; Quinones-Hinojosa A
    World Neurosurg; 2014; 82(1-2):e257-65. PubMed ID: 24508595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extent of resection affects prognosis for patients with glioblastoma in non-eloquent regions.
    Kow CY; Kim BJH; Park TI; Chen JCC; Vong CK; Kim JY; Shim V; Dragunow M; Heppner P
    J Clin Neurosci; 2020 Oct; 80():242-249. PubMed ID: 33099354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.
    Oppenlander ME; Wolf AB; Snyder LA; Bina R; Wilson JR; Coons SW; Ashby LS; Brachman D; Nakaji P; Porter RW; Smith KA; Spetzler RF; Sanai N
    J Neurosurg; 2014 Apr; 120(4):846-53. PubMed ID: 24484232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypo-fractionated IMRT for patients with newly diagnosed glioblastoma multiforme: a 6 year single institutional experience.
    Ciammella P; Galeandro M; D'Abbiero N; Podgornii A; Pisanello A; Botti A; Cagni E; Iori M; Iotti C
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1609-14. PubMed ID: 23453151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One decade of glioblastoma multiforme surgery in 342 elderly patients: what have we learned?
    Heiland DH; Haaker G; Watzlawick R; Delev D; Masalha W; Franco P; Machein M; Staszewski O; Oelhke O; Nicolay NH; Schnell O
    J Neurooncol; 2018 Nov; 140(2):385-391. PubMed ID: 30076585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.
    Pessina F; Navarria P; Cozzi L; Ascolese AM; Simonelli M; Santoro A; Clerici E; Rossi M; Scorsetti M; Bello L
    J Neurooncol; 2017 Oct; 135(1):129-139. PubMed ID: 28689368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.
    Woo PYM; Ho JMK; Tse TPK; Lam SW; Mak CHK; Chan DTM; Lee MWY; Wong ST; Chan KY; Poon WS
    J Clin Neurosci; 2019 May; 63():134-141. PubMed ID: 30712777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of maximal safe resection for glioblastoma including elderly and low Karnofsky performance status patients: retrospective review at a single institute.
    Uzuka T; Aoki H; Natsumeda M; Takahashi H; Fujii Y
    Neurol Med Chir (Tokyo); 2012; 52(8):570-6. PubMed ID: 22976140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report.
    Biau J; Chautard E; De Schlichting E; Dupic G; Pereira B; Fogli A; Müller-Barthélémy M; Dalloz P; Khalil T; Dillies AF; Durando X; Godfraind C; Verrelle P
    Radiat Oncol; 2017 Dec; 12(1):197. PubMed ID: 29212499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary Spinal Cord Glioblastoma Multiforme: A Retrospective Study of Patients at a Single Institution.
    Cheng X; Lou S; Huang S; Chen H; Liu J
    World Neurosurg; 2017 Oct; 106():113-119. PubMed ID: 28377242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of Tumor Volume in Glioblastoma Patients: Size Also Matters for Patients with Incomplete Resection.
    Bette S; Barz M; Wiestler B; Huber T; Gerhardt J; Buchmann N; Combs SE; Schmidt-Graf F; Delbridge C; Zimmer C; Kirschke JS; Meyer B; Ryang YM; Ringel F; Gempt J
    Ann Surg Oncol; 2018 Feb; 25(2):558-564. PubMed ID: 29159745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudoprogression in glioblastoma patients: the impact of extent of resection.
    Park HH; Roh TH; Kang SG; Kim EH; Hong CK; Kim SH; Ahn SS; Lee SK; Choi HJ; Cho J; Kim SH; Lee KS; Suh CO; Chang JH
    J Neurooncol; 2016 Feb; 126(3):559-66. PubMed ID: 26608521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.